abstract |
Inhibitors of the Wnt signaling pathway having the structure of formula I are disclosed with their pharmaceutical salts. The application of compounds of formula I to inhibit or modulate the Wnt signaling pathway is also disclosed. The compounds of formula I are capable of treating diseases caused by abnormal activation of the Wnt signaling pathway. |